Exciting Advancements for Rare Blood Diseases

Kathleen Weis, CEO

There are exciting advancements being made for rare blood diseases, such as anaplastic anemia, myelodysplastic syndromes (MDS) and myeloproliferative neoplasms like myelofibrosis, according to Kathleen Weis, CEO of the Anaplastic Anemia and MDS International Foundation.

Since these are difficult diseases to treat, research has been quite slow over the last decade or so, but continues to pick up, developing new treatments for patients with these diseases.

Music: Bensound
Print | cure Printing...